Tag: Skin Disorders: Misc.
Questionnaire Responses About Dermatology History Inconsistent
History of psoriasis consistently reported, whereas history of atopic dermatitis is not
COVID-19 Weakly Correlated With Chilblains Incidence
However, only 3.7 percent of the 456 patients with chilblains were positive for SARS-CoV-2
Risk Factors for PHACE Syndrome ID’d in Infantile Hemangiomas
Surface area of 25 cm2 or more, involvement of three or more locations linked to increased risk
Rituximab, Mycophenolate Mofetil Compared for Pemphigus Vulgaris
More patients receiving rituximab versus mycophenolate mofetil had sustained complete remission at week 52, fewer had disease flares
Delayed Hypersensitivity Reaction to Moderna COVID-19 Vaccine ID’d
Reaction occurred at or near injection site; reactions were pruritic, painful, and edematous pink plaques
Topical Corticosteroid Use in Pregnancy Not Tied to SGA, LBW
Risks for small for gestational age or low birth weight not increased with exposure to potent or very potent topical corticosteroids
Cutaneous AEs Linked to Immune Checkpoint Inhibitor Therapy
Cutaneous immune-related adverse events seen in 25 percent of cancer patients initiating ICI therapy with median onset time of 113 days
Delayed Local Reactions to mRNA-1273 Vaccination Reported
Reactions appeared near injection site at a median onset of day 8 after first dose; six of 12 patients had no recurrence after second dose
Cutaneous Findings Described for Children With MIS-C
Cutaneous findings varied among patients; annular plaques in the proximal medial lower extremities were common
Tirbanibulin Superior to Placebo for Actinic Keratosis
Significantly more patients treated with tirbanibulin had complete clearance of lesions at day 57
